A Highly Immunogenic Measles Virus-based Th1-biased COVID-19 Vaccine
Cindy Hoerner, Christoph Schuermann, Arne Auste, Aileen Ebenig, Samada Muraleedharan, Maike Herrmann, Barbara Schnierle, Michael D Muehlebach
This paper develops a measles virus-based vaccine against SARS-CoV-2 that induces strong Th1-biased immune responses in mice, supporting its potential as a safe and effective vaccine.
bioRxiv · Jul 11, 2020 · PreprintMicrobiology